Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply

The Trump administration is proposing tariffs on generic medications, CNBC reports. The move raises questions about potential impacts on drug prices, U.S. manufacturing, and which pharmaceutical companies would gain or lose, though the plan's details remain unclear.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton